US$ 27.69
glp-1 glucose Glucagon-like peptide-1 GLP-1 Agonists: A Comprehensive Overview
Description
As GLP-1 therapeutics continue to grow in demand, analytical techniques are evolving to deliver faster, more accurate, and highly reproducible results

The risk increases when GLP-1 drugs are combined with insulin or sulfonylureas, which is why dose adjustments are necessary in combination therapy
Our Plenary Panel Reveal is here bringing together leaders shaping the future of GLP-1 therapies in India

Regarding the TME, current evidence indicates that GLP-1RAs modulate antitumor immunity through multiple cellular pathways
